GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Beijing Northland Biotech Co Ltd (BJSE:430047) » Definitions » Research & Development

Beijing Northland Biotech Co (BJSE:430047) Research & Development : ¥42.13 Mil (TTM As of Mar. 2024)


View and export this data going back to 2020. Start your Free Trial

What is Beijing Northland Biotech Co Research & Development?

Research & Development is the aggregate amount of research and development expenses during the year. Beijing Northland Biotech Co's Research & Development for the three months ended in Mar. 2024 was ¥12.09 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2024 was ¥42.13 Mil.


Beijing Northland Biotech Co Research & Development Historical Data

The historical data trend for Beijing Northland Biotech Co's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Beijing Northland Biotech Co Research & Development Chart

Beijing Northland Biotech Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 33.02 24.14 43.20 56.41 43.49

Beijing Northland Biotech Co Quarterly Data
Mar19 Jun19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 13.45 16.42 11.47 2.15 12.09

Beijing Northland Biotech Co Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥42.13 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Beijing Northland Biotech Co  (BJSE:430047) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.


Beijing Northland Biotech Co Research & Development Related Terms

Thank you for viewing the detailed overview of Beijing Northland Biotech Co's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.


Beijing Northland Biotech Co (BJSE:430047) Business Description

Traded in Other Exchanges
N/A
Address
No. 5 Shangdi Kaikai Road, A406, Zhongguancun Biomedical Park, Haidian District, Beijing, CHN, 100085
Beijing Northland Biotech Co Ltd is a biopharmaceutical company specializing in the research and development, production, and sales of gene therapy drugs, recombinant protein drugs, and ophthalmic drugs.

Beijing Northland Biotech Co (BJSE:430047) Headlines

No Headlines